Comprehensive Non-invasive Versus Invasive Approach to Evaluate Cardiac Allograft Vasculopathy in Heart Transplantation: The CCTA-HTx Study
Circulation: Cardiovascular Imaging · 2025
DOI: 10.1161/circimaging.124.017197 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Circulation: Cardiovascular Imaging, 2025. Verfasst von Marta Belmonte und 21 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Center Aalst, Onze-Lieve-Vrouwziekenhuis (OLV) Clinic, Aalst, Belgium (M. Belmonte, P.P., M.M.V., M. Beles, H.O., R.S., G.E., M.S., R.…. Hauptthemen laut MEDLINE: Computed Tomography Angiography, Coronary Angiography, Coronary Artery Disease, Coronary Vessels. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Coronary computed tomography angiography (CCTA) is emerging as a valuable tool for noninvasive surveillance of cardiac allograft vasculopathy (CAV) in patients with heart transplant (HTx). We assessed the diagnostic performance of a comprehensive CCTA-based approach compared with the invasive reference, which includes invasive coronary angiography, intravascular ultrasound, and fractional flow reserve, for detecting CAV. METHODS: This was a multicenter prospective study including 37 patients with HTx who underwent CCTA, invasive coronary angiography, intravascular ultrasound, and fractional flow reserve. The comprehensive CCTA-based approach included quantitative and qualitative plaque analysis and functional assessment by fractional flow reserve derived from coronary computed tomography. CAV was diagnosed based on invasive coronary angiography (International Society for Heart and Lung Transplantation criteria) and intravascular ultrasound. Univariable logistic regression analysis was performed to test CCTA-derived predictors of CAV. The area under the curve and accuracy indicators were calculated to evaluate the performance and best cutoffs of CCTA predictors of CAV. RESULTS: The median interval between CCTA and HTx was 5 years. Among the 37 recipients, 23 (62.2%) were diagnosed with CAV. The integration of diameter stenosis and plaque morphology (including plaque burden at minimum lumen area >42% and percent atheroma volume >23%) at CCTA yielded the highest diagnostic performance (accuracy, 84%; sensitivity, 83%; specificity, 86%). The integration of ∆fractional flow reserve derived from coronary computed tomography trans-vessel gradient led to increased sensitivity, albeit with decreased specificity and overall accuracy. The noninvasive approach was associated with a lower contrast and radiation dose, compared with the invasive approach. CONCLUSIONS: A noninvasive strategy based on CCTA is accurate for managing patients with HTx. CCTA might be considered the preferred imaging modality for annual CAV surveillance after the first year post-HTx.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiovascular Center Aalst, Onze-Lieve-Vrouwziekenhuis (OLV) Clinic, Aalst, Belgium (M. Belmonte, P.P., M.M.V., M. Beles, H.O., R.S., G.E., M.S., R.D., W.H., J.V.K., J.B., M.V.).
- Department of Advanced Biomedical Sciences, University Federico II, Naples, Italy (M. Belmonte, M.M.V., G.E., A.L.).
- Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale Galeazzi Sant'Ambrogio, Department of Biomedical and Clinical Sciences, University of Milan, Italy (P.P., E.G.).
- Cardiology Unit, IRCCS Azienda Ospedaliera-Universitaria di Bologna, Italy (L.B., A.S., M.M., L.P., C.P.).
- Department of Medical and Surgical Sciences, Dipartimento di Scienze Mediche e Chirurgiche (DIMEC), Alma Mater Studiorum, University of Bologna, Italy (L.B., A.S., M.M., L.P., C.P.).
- Department of Clinical and Molecular Medicine, Sapienza University of Rome. Cardiology Unit, Sant'Andrea University Hospital, Rome, Italy (E.B.).
ORCID-Profile: Pasquale Paolisso, Monika Beles, Luca Bergamaschi, Angelo Sansonetti, Hirofumi Ohashi, Emanuele Gallinoro, Giuseppe Esposito, Monika Shumkova, Attilio Leone, Marco Masetti, Sofie Verstreken, Jan Van Keer, Luciano Potena, Carmine Pizzi, Jozeph Bartunek, Marc Vanderheyden
Zitieren
APA
Belmonte, M., Paolisso, P., Viscusi, M. M., Beles, M., Bergamaschi, L., Sansonetti, A., Ohashi, H., Seki, R., Gallinoro, E., Esposito, G., Shumkova, M., Leone, A., Masetti, M., Barbato, E., Verstreken, S., Dierckx, R., Heggermont, W., Van Keer, J., Potena, L., …, & Vanderheyden, M. (2025). Comprehensive Non-invasive Versus Invasive Approach to Evaluate Cardiac Allograft Vasculopathy in Heart Transplantation: The CCTA-HTx Study. Circulation: Cardiovascular Imaging. https://doi.org/10.1161/circimaging.124.017197
Vancouver
Belmonte M, Paolisso P, Viscusi MM, Beles M, Bergamaschi L, Sansonetti A, et al. Comprehensive Non-invasive Versus Invasive Approach to Evaluate Cardiac Allograft Vasculopathy in Heart Transplantation: The CCTA-HTx Study. Circulation: Cardiovascular Imaging. 2025. doi:10.1161/circimaging.124.017197
BibTeX
@article{Belmonte2025,
author = {Belmonte, Marta and Paolisso, Pasquale and Viscusi, Michele Mattia and Beles, Monika and Bergamaschi, Luca and Sansonetti, Angelo and Ohashi, Hirofumi and Seki, Ruiko and Gallinoro, Emanuele and Esposito, Giuseppe and Shumkova, Monika and Leone, Attilio and Masetti, Marco and Barbato, Emanuele and Verstreken, Sofie and Dierckx, Riet and Heggermont, Ward and Van Keer, Jan and Potena, Luciano and Pizzi, Carmine and Bartunek, Jozeph and Vanderheyden, Marc},
title = {Comprehensive Non-invasive Versus Invasive Approach to Evaluate Cardiac Allograft Vasculopathy in Heart Transplantation: The CCTA-HTx Study},
journal = {Circulation: Cardiovascular Imaging},
year = {2025},
doi = {10.1161/circimaging.124.017197}
}
EUVIMED